Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8657 |
High Similarity |
NPD3027 |
Phase 3 |
0.8615 |
High Similarity |
NPD3705 |
Approved |
0.8411 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8244 |
Intermediate Similarity |
NPD1357 |
Approved |
0.8203 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.8158 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8158 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8158 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8151 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8071 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8071 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8047 |
Intermediate Similarity |
NPD228 |
Approved |
0.8038 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7986 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7971 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7961 |
Intermediate Similarity |
NPD37 |
Approved |
0.7943 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7943 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7914 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7908 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7908 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7891 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7891 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7877 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7842 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.781 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7664 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7625 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7593 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7582 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7569 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7545 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7535 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7517 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7517 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7515 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7467 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7431 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7417 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.741 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7405 |
Intermediate Similarity |
NPD2684 |
Approved |
0.74 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7397 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7397 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7394 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7391 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7391 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7389 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7383 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7357 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7351 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7343 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7315 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7313 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7299 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7285 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7255 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD7243 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7248 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7248 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7237 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7233 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD5109 |
Approved |
0.719 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7181 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7181 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7175 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7161 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7153 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7153 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD4210 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7125 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7122 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7121 |
Intermediate Similarity |
NPD968 |
Approved |
0.7115 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7113 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7111 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7101 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD5604 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7095 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7078 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7075 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7075 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7067 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7063 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7063 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD3685 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7055 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD27 |
Approved |
0.7048 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7048 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7042 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7027 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7025 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7021 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7021 |
Intermediate Similarity |
NPD5846 |
Approved |
0.702 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.702 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7019 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7019 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7014 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7011 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.6994 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD2233 |
Approved |
0.6993 |
Remote Similarity |
NPD2231 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD2232 |
Approved |
0.6993 |
Remote Similarity |
NPD2235 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD2230 |
Approved |
0.6988 |
Remote Similarity |
NPD2970 |
Approved |
0.6988 |
Remote Similarity |
NPD2969 |
Approved |
0.6986 |
Remote Similarity |
NPD9494 |
Approved |
0.6981 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD2563 |
Approved |
0.6975 |
Remote Similarity |
NPD2560 |
Approved |
0.697 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6968 |
Remote Similarity |
NPD5241 |
Discontinued |
0.6959 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD6896 |
Approved |
0.6954 |
Remote Similarity |
NPD6895 |
Approved |
0.6953 |
Remote Similarity |
NPD2860 |
Approved |
0.6953 |
Remote Similarity |
NPD2859 |
Approved |
0.695 |
Remote Similarity |
NPD5585 |
Approved |
0.6944 |
Remote Similarity |
NPD6583 |
Phase 3 |
0.6944 |
Remote Similarity |
NPD6582 |
Phase 2 |
0.694 |
Remote Similarity |
NPD290 |
Approved |
0.6937 |
Remote Similarity |
NPD4675 |
Approved |
0.6937 |
Remote Similarity |
NPD4678 |
Approved |
0.6934 |
Remote Similarity |
NPD5535 |
Approved |
0.6933 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6928 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6928 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6928 |
Remote Similarity |
NPD3051 |
Approved |
0.6928 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD7310 |
Approved |
0.6919 |
Remote Similarity |
NPD7311 |
Approved |
0.6919 |
Remote Similarity |
NPD7312 |
Approved |
0.6919 |
Remote Similarity |
NPD7313 |
Approved |
0.6918 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD4624 |
Approved |
0.6914 |
Remote Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.6913 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6913 |
Remote Similarity |
NPD554 |
Clinical (unspecified phase) |
0.691 |
Remote Similarity |
NPD5582 |
Discontinued |
0.6909 |
Remote Similarity |
NPD5494 |
Approved |
0.6906
|
Remote Similarity |
NPD709 |
Approved |